⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7518595 | 1.00 | — | — | |
| SCHEMBL7517451 | 1.00 | — | — | |
| SCHEMBL9306682 | 0.84 | TSHR (0.50) | — | |
| SCHEMBL7149918 | 0.78 | FOLH1 (0.52) | — | |
| SCHEMBL2889051 | 0.78 | ALDH1A1 (0.42) | — | |
| SCHEMBL2889047 | 0.78 | ALDH1A1 (0.42) | — | |
| SCHEMBL7519670 | 0.77 | — | — | |
| SCHEMBL7518986 | 0.77 | — | — | |
| SCHEMBL7518992 | 0.77 | — | — | |
| SCHEMBL5729462 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11680923-B2 | Technologies using surface-modified pseudo-graphite | ABB SCHWEIZ AG (CH) | 2023-06-20 | — | — | US | disclosed |
| US-20200284751-A1 | Technologies Using Surface-Modified Pseudo-Graphite | ABB SCHWEIZ AG (CH) | 2020-09-10 | — | — | US | disclosed |
| US-20020042055-A1 | Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions | MAXYGEN, INC. | 2002-04-11 | — | — | US | disclosed |
| WO-2001046476-A1 | ALTERATION OF HYDROLASE GENES AND SCREENING OF THE RESULTING LIBRARIES FOR THE ABILITY TO CATALYZE SPECIFIC REACTIONS | MAXYGEN, INC. (US) | 2001-06-28 | — | — | WO | disclosed |
| CN-1048606-A | Has the sensitization static negative that contains leuco dye that prints off image | DU PONT (US) | 1991-01-16 | — | — | CN | disclosed |